查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1766100

长读定序市场：2032 年未来预测－依产品、技术、应用、最终使用者和地区进行分析

Long Read Sequencing Market Forecasts to 2032 - Global Analysis By Product, Technology (Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Synthetic Long-Read Sequencing and Other Technologies), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球长读定序市场预计在 2025 年将达到 13.2 亿美元，到 2032 年将达到 58.7 亿美元，预测期内的复合年增长率为 23.7%。

一种被称为「长读定序」的技术可以创建长而连续的DNA链读取，通常长度为数千到数百万个碱基对。与传统的短读技术相比，它可以更精确地定位包含结构变异、重复序列和全长转录物的复杂基因组区域。牛津奈米孔平台和太平洋生物科学公司的SMRT等技术使即时定序和极简样品製备成为可能。长读定序是基因组学研究中的强大工具，因为它透过提供遗传资讯的背景和连续性来改善基因组组装、临床诊断和演化研究。

精确基因组组装的需求不断增加

复杂的基因组区域难以透过短读长定序方法解析，但长读长定序方法使其成为可能。它可以更精确地检测大片段插入和缺失、重复序列以及结构变异。个人化医疗、疾病研究和演化研究等领域的应用都依赖这种准确性。随着学术界和医疗相关人员越来越重视准确且全面的基因数据，长读长平台正变得越来越受欢迎。为了满足日益增长的需求，业内公司正在投资先进的定序系统。

高成本、错误率高

由于技术要求高，需要昂贵的设备和化学品，限制了它们在小型实验室中的应用。由于每个样本的定序成本高昂，它们在更广泛的临床和科研环境中的应用也受到限制。此外，长读长定序输出的错误率会影响资料的准确性和可靠性。这通常需要对短读长进行额外的定序以进行检验，这既昂贵又耗时。因此，用户不愿完全迁移到长读长平台，限制了市场扩张。

扩大在临床诊断和个人化医疗的应用

长读长定序可以精确检测基因融合、复杂的基因组区域以及短读长定序经常忽略的结构变化。这种精准度对于诊断复杂疾病和罕见基因异常至关重要。它能够根据每位患者独特的基因组成客製化治疗方案，从而实现个人化医疗。此外，该技术还有助于癌症基因组分析和非侵入性产前检测。随着精准医疗和客製化医疗需求的日益增长，长读长定序正日益普及。

来自短读技术和新兴定序平台的竞争

短读长方法易于采用，具有成熟且广泛可用的基础设施和用户友好的方法。由于其高准确度和高通量，短读长方法在许多临床和研究应用中仍然被广泛使用。新的平台正在弥补读长的差距，同时又不牺牲价格。长读长供应商面临创新和快速降价的压力。因此，市场扩张面临缓慢的采用和日益激烈的价格竞争。

COVID-19的影响

COVID-19 疫情加速了基因组学研究和诊断方法的开发，对长读长定序市场产生了积极影响。精准快速病原体检测的需求日益增长，刺激了对定序技术的投资。长读长定序在研究病毒突变、改进监测和辅助疫苗研发方面发挥了关键作用。此外，政府与生技公司之间的合作也扩大了全球定序能力。儘管最初供应链中断，但由于人们对基因组学工具在医疗准备和回应方面的认识不断提高，市场实现了显着增长。

预计在预测期内，消耗品部分将成长至最大的部分。

由于每次定序运作都有固定的需求，预计耗材领域将在预测期内占据最大的市场占有率。耗材包括试剂、套件和流动槽，这些对于准确且有效率地产生长读长数据至关重要。耗材技术的进步提高了读取长度、准确性和吞吐量，吸引了更多的研究和临床应用。基因组学和肿瘤学等领域对长读长定序的日益普及，推动了对高性能耗材的需求。这种稳定成长的需求将增强整体市场的成长和盈利。

预计在预测期内，医院和医疗保健提供者部门将以最高的复合年增长率成长。

由于患者诊断和个人化治疗对准确且全面的基因组数据的需求不断增长，预计医院和医疗保健提供者领域将在预测期内实现最高增长。这些机构越来越多地采用长读长定序来识别短读长方法可能遗漏的复杂基因突变。罕见遗传疾病和癌症的增加进一步推动了临床环境中对准确基因组分析的需求。将长读长定序技术整合到医院实验室可以改善诊断工作流程并提升病患预后。此外，政府资助和官民合作关係正在推动先进测序技术在医疗保健基础设施中的应用。

比最大的地区

在预测期内，亚太地区预计将占据最大的市场占有率，这得益于基因组研究投入的增加、政府对精准医疗的支持以及遗传疾病盛行率的上升。中国、日本和印度等国家正在扩大其生物技术基础设施和研究能力。当地大学与全球生物技术公司之间的合作正在促进技术的采用。此外，个人化医疗需求的不断增长以及人们对基因组检测的认识不断提高，也全部区域的市场扩张做出了重大贡献。

复合年增长率最高的地区：

预计北美地区在预测期内的复合年增长率最高，这得益于该地区拥有领先的企业、先进的医疗基础设施以及高额的研发支出。尤其是美国，它在尖端基因组技术在临床和研究应用方面的应用方面处于领先地位。该地区受益于完善的资金筹措架构、健全的监管制度以及广泛的产学合作。与亚太地区不同，北美市场成熟，能够快速部署创新的群体定序平台和大规模的群体基因组学计画。

免费客製化服务

本报告的所有订阅者均可享有以下免费自订选项之一：

  • 公司简介
    • 对其他公司（最多 3 家）进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 简介

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 分析方法
  • 分析材料
    • 主要研究资料
    • 二手研究资讯来源
    • 先决条件

第三章市场走势分析

  • 介绍
  • 驱动程式
  • 限制因素
  • 市场机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代产品的威胁
  • 新参与企业的威胁
  • 企业之间的竞争

5. 全球长读定序市场（依产品）

  • 装置
    • SMRT定序仪
    • 奈米孔定序仪
  • 耗材
    • 试剂
    • 流动池
  • 服务
    • 定序服务
    • 数据分析服务

6. 全球长读定序市场（依技术）

  • 单分子即时（SMRT）定序
  • 奈米孔定序
  • 合成长读定序
  • 其他技术

7. 全球长读定序市场（按应用）

  • 基因组学
    • 全基因组定序（WGS）
    • 从头定序
    • 结构突变检测
  • 转录组学
    • 全长mRNA定序
    • 异构体鑑定
  • 表观遗传学
    • DNA甲基化分析
    • 组蛋白修饰检测
  • 总体基因体学
  • 其他用途

8. 全球长读定序市场（依最终用户）

  • 製药和生物技术公司
  • 临床实验室
  • 医院和医疗机构
  • CRO（委外研发机构）
  • 其他最终用户

9. 全球长读定序市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併与收购（M&A）
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Illumina Inc.
  • BGI Genomics
  • MGI Tech
  • 10x Genomics
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Qiagen
  • Bionano Genomics
  • Element Biosciences
  • Quantapore Inc.
  • Universal Sequencing Technology
  • BaseClear BV
  • Cantata Bio, LLC
  • Future Genomics Technologies BV
  • MicrobesNG
  • SeqLL, Inc.
Product Code: SMRC29956

According to Stratistics MRC, the Global Long Read Sequencing Market is accounted for $1.32 billion in 2025 and is expected to reach $5.87 billion by 2032 growing at a CAGR of 23.7% during the forecast period. The technique known as "long read sequencing" creates lengthy, continuous reads of DNA strands, usually ranging in length from thousands to millions of base pairs. It enables more precise mapping of intricate genomic areas, including structural variations, repetitive sequences, and full-length transcripts, in contrast to conventional short-read techniques. Real-time sequencing and minimal sample preparation are made possible by technologies such as Oxford Nanopore's platforms and Pacific Biosciences' SMRT. Long read sequencing is a potent tool in genomics research because it improves genome assembly, clinical diagnostics, and evolutionary studies by giving genetic information more context and continuity.

Market Dynamics:

Driver:

Increasing demand for accurate genome assembly

Complex genomic areas are challenging to resolve with short reads, but long read sequencing methods make this possible. They provide more precision in detecting big insertions or deletions, repetitive sequences, and structural alterations. Applications in personalised treatment, disease research, and evolutionary studies all depend on this accuracy. Long read platforms are becoming more and more popular as academics and medical professionals place a higher value on accurate and comprehensive genetic data. In order to satisfy this rising demand, industry participants are investing in sophisticated sequencing systems.

Restraint:

High cost and error rates

The sophisticated technology required necessitates costly equipment and chemicals, which limits small labs' access to it. Its use in extensive clinical and scientific settings is restricted by the high expense of sequencing each sample. Furthermore, the correctness and dependability of data are jeopardised by the error rates in long-read outputs. This frequently calls for additional short-read sequencing for validation, which raises the expense and time. As a result, users hesitate to fully transition to long-read platforms, slowing market expansion.

Opportunity:

Growing use in clinical diagnostics and personalized medicine

Gene fusions, complicated genomic areas, and structural changes that short reads frequently overlook can be accurately detected by long read sequencing. For the diagnosis of complex diseases and rare genetic abnormalities, this accuracy is essential. This helps personalised medicine by customising care according to each patient's distinct genetic composition. Additionally, the technology helps cancer genomics and non-invasive prenatal diagnostics. Long read sequencing is gaining traction as the need for accurate, customised healthcare increases.

Threat:

Competition from short read technologies and emerging sequencing platforms

Adoption is facilitated by the established, widely used infrastructure and user familiarity of short read methods. Because of its precision and high throughput, short reads are still used in many clinical and research applications. New platforms are bridging the read-length divide without sacrificing price. Long read suppliers are under pressure to innovate and cut prices quickly as a result. Market expansion is therefore confronted with slower adoption and more intense pricing competition.

Covid-19 Impact

The COVID-19 pandemic positively impacted the Long Read Sequencing market by accelerating genomic research and diagnostic development. Increased demand for accurate and rapid pathogen detection drove investments in sequencing technologies. Long read sequencing played a vital role in studying virus mutations, improving surveillance, and supporting vaccine development. Additionally, collaborative efforts between governments and biotech firms expanded sequencing capacity globally. Despite initial supply chain disruptions, the market experienced significant growth due to heightened awareness of genomic tools in healthcare preparedness and response.

The consumables segment is expected to be the largest during the forecast period

The consumables segment is expected to account for the largest market share during the forecast period, due to ensured recurring demand through each sequencing run. These include reagents, kits, and flow cells, which are essential for accurate and efficient long-read data generation. Technological advancements in consumables enhance read length, accuracy, and throughput, attracting more research and clinical applications. As the adoption of long-read sequencing grows in fields like genomics and oncology, the need for high-performance consumables rises. This steady and expanding demand strengthens the overall market growth and profitability.

The hospitals & healthcare providers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals & healthcare providers segment is predicted to witness the highest growth rate, due to the growing demand for accurate and comprehensive genomic data for patient diagnostics and personalized treatment. These institutions increasingly adopt long read sequencing to identify complex genetic variations that short read methods may miss. Rising incidences of rare genetic disorders and cancer further drive the need for precise genomic analysis in clinical settings. Integration of long read sequencing into hospital labs improves diagnostic workflows and enhances patient outcomes. Additionally, government funding and public-private partnerships support the adoption of advanced sequencing technologies in healthcare infrastructure.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increasing investments in genomics research, government support for precision medicine, and the rising prevalence of genetic disorders. Countries like China, Japan, and India are expanding their biotechnology infrastructure and research capabilities. Collaborations between local universities and global biotech firms are fuelling technological adoption. Moreover, the growing demand for personalized healthcare and increasing awareness about genomic testing contribute significantly to market expansion across the region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to the presence of major players, advanced healthcare infrastructure, and high R&D expenditure. The U.S., in particular, leads in the adoption of cutting-edge genomic technologies for clinical and research applications. The region benefits from established funding frameworks, robust regulatory systems, and widespread academic-industry collaborations. Unlike Asia Pacific, North America's market maturity allows for rapid deployment of innovative sequencing platforms and large-scale population genomics initiatives.

Key players in the market

Some of the key players profiled in the Long Read Sequencing Market include Pacific Biosciences, Oxford Nanopore Technologies, Illumina Inc., BGI Genomics, MGI Tech, 10x Genomics, Agilent Technologies, Thermo Fisher Scientific, Qiagen, Bionano Genomics, Element Biosciences, Quantapore Inc., Universal Sequencing Technology, BaseClear BV, Cantata Bio, LLC, Future Genomics Technologies B.V., MicrobesNG and SeqLL, Inc.

Key Developments:

In May 2025, PacBio expanded its distribution agreement with Xi'an-based Haorui Gene, making Haorui the distributor for the Vega benchtop system across China and providing product support. Haorui had already deployed 10 Sequel II and Revio sequencers, focusing on blood typing genomics and HLA testing.

In October 2024, PacBio signed a research collaboration agreement to accelerate cancer genomics research in Asia, leveraging both its long-read (Revio) and short-read (Onso) sequencing platforms. The collaboration, supported by DKSH, aims to expand multi-omics research and precision oncology in the region.

In July 2024, Oxford Nanopore and Plasmidsaurus entered an expanded, multi-year strategic collaboration to transform the plasmid sequencing market using nanopore technology. This partnership aims to deliver rapid, high-quality, and cost-effective whole-plasmid sequencing, with plans to co-develop new technologies and applications for microbial and gene therapy use cases.

Products Covered:

  • Instruments
  • Consumables
  • Services

Technologies Covered:

  • Single-Molecule Real-Time (SMRT) Sequencing
  • Nanopore Sequencing
  • Synthetic Long-Read Sequencing
  • Other Technologies

Applications Covered:

  • Genomics
  • Transcriptomics
  • Epigenetics
  • Metagenomics
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biotechnology Companies
  • Clinical Laboratories
  • Hospitals & Healthcare Providers
  • Contract Research Organizations (CROs)
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Long Read Sequencing Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
    • 5.2.1 SMRT Sequencers
    • 5.2.2 Nanopore Sequencers
  • 5.3 Consumables
    • 5.3.1 Reagents
    • 5.3.2 Flow Cells
  • 5.4 Services
    • 5.4.1 Sequencing Services
    • 5.4.2 Data Analysis Services

6 Global Long Read Sequencing Market, By Technology

  • 6.1 Introduction
  • 6.2 Single-Molecule Real-Time (SMRT) Sequencing
  • 6.3 Nanopore Sequencing
  • 6.4 Synthetic Long-Read Sequencing
  • 6.5 Other Technologies

7 Global Long Read Sequencing Market, By Application

  • 7.1 Introduction
  • 7.2 Genomics
    • 7.2.1 Whole Genome Sequencing (WGS)
    • 7.2.2 De Novo Sequencing
    • 7.2.3 Structural Variant Detection
  • 7.3 Transcriptomics
    • 7.3.1 Full-Length mRNA Sequencing
    • 7.3.2 Isoform Identification
  • 7.4 Epigenetics
    • 7.4.1 DNA Methylation Analysis
    • 7.4.2 Histone Modification Detection
  • 7.5 Metagenomics
  • 7.6 Other Applications

8 Global Long Read Sequencing Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical & Biotechnology Companies
  • 8.3 Clinical Laboratories
  • 8.4 Hospitals & Healthcare Providers
  • 8.5 Contract Research Organizations (CROs)
  • 8.6 Other End Users

9 Global Long Read Sequencing Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Pacific Biosciences
  • 11.2 Oxford Nanopore Technologies
  • 11.3 Illumina Inc.
  • 11.4 BGI Genomics
  • 11.5 MGI Tech
  • 11.6 10x Genomics
  • 11.7 Agilent Technologies
  • 11.8 Thermo Fisher Scientific
  • 11.9 Qiagen
  • 11.10 Bionano Genomics
  • 11.11 Element Biosciences
  • 11.12 Quantapore Inc.
  • 11.13 Universal Sequencing Technology
  • 11.14 BaseClear BV
  • 11.15 Cantata Bio, LLC
  • 11.16 Future Genomics Technologies B.V.
  • 11.17 MicrobesNG
  • 11.18 SeqLL, Inc.

List of Tables

  • Table 1 Global Long Read Sequencing Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Long Read Sequencing Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Long Read Sequencing Market Outlook, By Instruments (2024-2032) ($MN)
  • Table 4 Global Long Read Sequencing Market Outlook, By SMRT Sequencers (2024-2032) ($MN)
  • Table 5 Global Long Read Sequencing Market Outlook, By Nanopore Sequencers (2024-2032) ($MN)
  • Table 6 Global Long Read Sequencing Market Outlook, By Consumables (2024-2032) ($MN)
  • Table 7 Global Long Read Sequencing Market Outlook, By Reagents (2024-2032) ($MN)
  • Table 8 Global Long Read Sequencing Market Outlook, By Flow Cells (2024-2032) ($MN)
  • Table 9 Global Long Read Sequencing Market Outlook, By Services (2024-2032) ($MN)
  • Table 10 Global Long Read Sequencing Market Outlook, By Sequencing Services (2024-2032) ($MN)
  • Table 11 Global Long Read Sequencing Market Outlook, By Data Analysis Services (2024-2032) ($MN)
  • Table 12 Global Long Read Sequencing Market Outlook, By Technology (2024-2032) ($MN)
  • Table 13 Global Long Read Sequencing Market Outlook, By Single-Molecule Real-Time (SMRT) Sequencing (2024-2032) ($MN)
  • Table 14 Global Long Read Sequencing Market Outlook, By Nanopore Sequencing (2024-2032) ($MN)
  • Table 15 Global Long Read Sequencing Market Outlook, By Synthetic Long-Read Sequencing (2024-2032) ($MN)
  • Table 16 Global Long Read Sequencing Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 17 Global Long Read Sequencing Market Outlook, By Application (2024-2032) ($MN)
  • Table 18 Global Long Read Sequencing Market Outlook, By Genomics (2024-2032) ($MN)
  • Table 19 Global Long Read Sequencing Market Outlook, By Whole Genome Sequencing (WGS) (2024-2032) ($MN)
  • Table 20 Global Long Read Sequencing Market Outlook, By De Novo Sequencing (2024-2032) ($MN)
  • Table 21 Global Long Read Sequencing Market Outlook, By Structural Variant Detection (2024-2032) ($MN)
  • Table 22 Global Long Read Sequencing Market Outlook, By Transcriptomics (2024-2032) ($MN)
  • Table 23 Global Long Read Sequencing Market Outlook, By Full-Length mRNA Sequencing (2024-2032) ($MN)
  • Table 24 Global Long Read Sequencing Market Outlook, By Isoform Identification (2024-2032) ($MN)
  • Table 25 Global Long Read Sequencing Market Outlook, By Epigenetics (2024-2032) ($MN)
  • Table 26 Global Long Read Sequencing Market Outlook, By DNA Methylation Analysis (2024-2032) ($MN)
  • Table 27 Global Long Read Sequencing Market Outlook, By Histone Modification Detection (2024-2032) ($MN)
  • Table 28 Global Long Read Sequencing Market Outlook, By Metagenomics (2024-2032) ($MN)
  • Table 29 Global Long Read Sequencing Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 30 Global Long Read Sequencing Market Outlook, By End User (2024-2032) ($MN)
  • Table 31 Global Long Read Sequencing Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
  • Table 32 Global Long Read Sequencing Market Outlook, By Clinical Laboratories (2024-2032) ($MN)
  • Table 33 Global Long Read Sequencing Market Outlook, By Hospitals & Healthcare Providers (2024-2032) ($MN)
  • Table 34 Global Long Read Sequencing Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN)
  • Table 35 Global Long Read Sequencing Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.